Related Experiment Videos
Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children
Insights
This study found that phenytoin did not significantly reduce late post-traumatic epilepsy in children after head injury. The anti-seizure medication showed no benefit compared to placebo in preventing epilepsy in pediatric patients.
Area of Science:
- Pediatric Neurology
- Trauma Care
- Clinical Pharmacology
Background:
- Head injuries in children can lead to epilepsy.
- Early intervention strategies are crucial for preventing neurological complications.
- The efficacy of anti-epileptic drugs in preventing post-traumatic epilepsy requires investigation.
Purpose of the Study:
- To evaluate the effectiveness of phenytoin in preventing late post-traumatic epilepsy in children.
- To assess the impact of early phenytoin administration on seizure incidence following head trauma.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted.
- 41 pediatric patients with head injuries were enrolled.
- Participants received either phenytoin or placebo intravenously/intramuscularly within 24 hours of admission and followed for 18 months.
Main Results:
- No statistically significant difference was observed in the percentage of children experiencing seizures between the phenytoin and placebo groups (p = 0.25).
- Phenytoin administration did not reduce the incidence of late post-traumatic epilepsy.
Conclusions:
- Early administration of phenytoin is not effective in preventing late post-traumatic epilepsy in children.
- Further research may be needed to explore alternative prophylactic treatments for post-traumatic epilepsy in pediatric populations.
Abstract:
We report the results of a randomized, double-blind, placebo-controlled study to determine whether phenytoin administered soon after a head injury lessens the incidence of late post-traumatic epilepsy in children. 41 patients were randomized into either a phenytoin or placebo group and followed for 18 months. The patients were administered phenytoin or placebo intravenously or intramuscularly within 24 h of hospital admission. The patients were parenterally administered phenytoin or placebo until oral doses could be tolerated. There was no significant difference in the percentage of children having seizures in the treated and placebo groups (p = 0.25).